Login
$MRNA
$214.08 After hours

Company Executives

Officer Age In this role Joined Source
Stéphane Bancel Also a director
Chief Executive Officer
53 Since 2011
15 years
2011
Stephane Bancel
Chief Executive Officer
Title from the Form 4 dated Aug 5, 2026
Not stated Not stated Not stated
James Mock
Chief Financial Officer
49 Since 2022
4 years
2022
Stephen Hoge
President
50 Since 2024
2 years
2013
Juan Andres
Chief Operating Officer
Title from the Form 4 dated Nov 5, 2026
Not stated Not stated Not stated
David Berman
Chief Development Officer
55 Since 2026
this year
2026
Tracey Franklin
Chief People and Digital Technology Officer
46 Since 2024
2 years
2019
Shannon Thyme Klinger
Chief Legal Officer and Corporate Secretary
54 Since 2021
5 years
2021
Soria Ester Banque
Chief Commercial Officer
Title from the Form 4 dated Jul 5, 2026
Not stated Not stated Not stated
Rose Loughlin
Executive Vice President, Research
42 Since 2024
2 years
2016

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Mar 16, 2026 · updated by the 8-K of Jul 8, 2026

Directors
10
serving now
Independent
8 of 9
stated in the proxy; 1 not stated
Average tenure
8.1 years
from year joined
CEO also chairs the board
No
Noubar Afeyan
Director Age On board Independent Committees Other public boards 2025 pay Source
Noubar Afeyan
63 2010
16 years
Independent None stated Generate Biomedicines, Inc. Not stated
Stéphane Bancel
53 2011
15 years
Not independent None stated Generate Biomedicines, Inc. Paid as CEO
Sandra Horning
77 2020
6 years
Independent
Product and Technology · Chair Nominating and Corporate Governance
Revolution Medicines, Inc. $563,290
Abbas Hussain
61 2024
2 years
Independent
Audit Product and Technology
None stated $543,290
Elizabeth Nabel
74 2015
11 years
Independent
Compensation and Talent Product and Technology
Medtronic plc $543,290
François Nader
69 2019
7 years
Independent
Compensation and Talent · Chair Nominating and Corporate Governance · Chair
Tectonic Therapeutic, Inc. $583,267
David Rubenstein
76 2024
2 years
Independent
Nominating and Corporate Governance Committee
The Carlyle Group $543,272
Elizabeth Tallett
76 2020
6 years
Independent
Audit · Chair Compensation and Talent
Qiagen, Inc. $563,277
Sagan
Not stated Not stated Independent None stated None stated Not stated
Michael McDonnell Joined Jul 8, 2026
- - -
Audit Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Mar 16, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support